forum

GLAXO Share Price Discussion

GlaxoSmithKline Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
... Read more
GLAXO Share Price *
1,407.3 +42.75 (3.13%)
* (quote may be delayed)

GLAXO Discussion Forum


GLAXO - chart - 365719
Glaxo
Like
reply
Reply
share
Share

CASH INTRADAY CALL (11 SEPT 2019)
GLAXO BUY ABOVE 1333M SL - 1321, TGT - 1364 & 1402
Like
reply
Reply (1)
share
Share
Latest replies
Tipu Pahan @tipupahan
Sep 12 3:47 AM

FROM 1333 TO 1400 (67 POINTS) PROFIT (+5% UP)
Pharma companies cheer good monsoon as demand for anti-infective drugs rises
Anti-infective drugs grew at 15.3 percent YoY in August, compared to Indian pharmaceutical market growth of 9.4 percent.
Moneycontrol
Like
reply
Reply
share
Share
Government scrambles to address shortage of rabies vaccine after GSK exit
Sources within the vaccine industry said that one of the main reasons for the current shortage was due to the exit of Chiron Behring Vaccines, a unit of GlaxoSmithKline (GSK).
Moneycontrol
Like
reply
Reply
share
Share
Focus on selective products, therapies starting to pay dividends: GSK Pharma
Vaidheesh hinted at new launches such as a vaccine (Bexsero) to protect infants against Meningitis B and a new drug to treat autoimmune disorders
Moneycontrol
Like
reply
Reply
share
Share
Hold GlaxoSmithKline Consumer Healthcare; target of Rs 7972: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7972 in its research report dated August 05, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share

GLAXO - chart - 266756
Galxo
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share

It will grow huge in next 2 days
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • GLAXO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization22,020.76
    Enterprise Value20,865.43
    Price to Earnings50.18
    Price to Book Value10.28
    Return on Capital Employed0.26
    Return on Equity0.17
    Face Value10
    Dividend Yield0.02
  • GLAXO Share Price - Technicals

    keyboard_arrow_down
    GLAXO - 52 Week High₹1,712.55
    GLAXO - 52 Week Low₹1,130
  • GLAXO - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    21-May-19Motilal OswalNeutral1,350
    23-Oct-18CentrumSell950
    26-Jul-18CentrumSell950
    25-May-18Motilal OswalNeutral1,250
    3-Feb-18Motilal OswalNeutral1,250
    View all GLAXO - Share Targets - Broker Reports
  • GLAXO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 181366141413551409.45
    Sep 171385.251406.4513611364.55
    Sep 161362.71399.413541385.25
    Sep 131380.0513861352.11362.7
    Sep 1213901403.051362.11375.8
  • GLAXO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,273.97
    30 Day Moving Average₹1,251.48
    50 Day Moving Average₹1,224.11
    100 Day Moving Average₹1,242.52
    200 Day Moving Average₹1,308.08
  • GLAXO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2,895.882,994.51-0.03
    Operating Profit508.44417.50.22
    Profit Before Tax541.58511.080.06
    Net Income351.99336.780.05
  • GLAXO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds2,1422,079.950.03
    Total Liabilities1,7671,901.27-0.07
    Total Assets3,9093,981.22-0.02
  • GLAXO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity474.77233.131.04
    Cash from Investing Activity-107.01303.24-1.35
    Cash from Financing Activity-306.63-510.76-0.4
    Net Cash Flow61.1225.611.39
  • GLAXO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.090.11
    Return on Equity0.170.17
    Return on Capital Employed0.260.25
  • GLAXO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.12
    3 Year CAGR Growth in Operating Profit-0.12
    3 Year CAGR Growth in EBIDTA-0.25
    3 Year CAGR Growth in Net Income-0.25
    3 Yr CAGR Growth - Diluted EPS-0.25
  • GLAXO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.1
    5 Year CAGR Growth in Operating Profit-0.24
    5 Year CAGR Growth in EBIDTA-0.33
    5 Year CAGR Growth in Net Income-0.39
    3 Yr CAGR Growth - Diluted EPS-0.39
  • GLAXO Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 9 11:33 PM
    Pharma companies cheer good monsoon as demand for anti-infective drugs rises
    Moneycontrol
    NewsBot
    Sep 4 12:13 AM
    Government scrambles to address shortage of rabies vaccine after GSK exit
    Moneycontrol
    NewsBot
    Aug 21 3:29 PM
    Focus on selective products, therapies starting to pay dividends: GSK Pharma
    Moneycontrol
    NewsBot
    Aug 7 9:38 PM
    Hold GlaxoSmithKline Consumer Healthcare; target of Rs 7972: Prabhudas Lilladher
    moneycontrol.com
    NewsBot
    Jul 22 10:38 PM
    NewsBot
    Jul 16 2:38 AM
    NewsBot
    Jul 10 7:53 PM
    NewsBot
    Jul 9 10:18 PM
    NewsBot
    Jun 15 3:18 AM
    NewsBot
    May 24 7:13 PM
  • GLAXO - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.